Logo

CST, TTP LabTech Partner on Cell Analysis Assays

Jan 31, 2008
NEW YORK (GenomeWeb News) – Cell Signaling Technology today said that it will collaborate with TTP LabTech on developing antibody-based assays for high-content cellular analysis.
 
Danvers, Mass.-based CST intends to use its rabbit monoclonal antibody technology in developing and optimizing a catalog of high-content assays for cellular pathway profiling on TTP LabTech’s Acumen Explorer/eX3 platform. CST said that it will sell the assays to the drug discovery market and also offer them in its profiling services.
 
Further terms of the alliance were not disclosed.

Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.